Overview

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

Status:
Unknown status

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

The purposes of this study are: 1. To understand whether the use of HIV therapy in persons with more advanced HIV disease results in greater side effects. 2. To determine whether these side effects can be related to greater activation of the immune system.

Phase:

Phase 4

Details

Lead Sponsor:

University of Cincinnati

Collaborators:

Abbott
Gilead Sciences

Treatments:

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Lopinavir
Ritonavir
Tenofovir